|
GS185131: GO:0044699 single-organism process
|
|
GS207306: GO:0080134 regulation of response to stress
|
|
GS126824: phenylalanyl-prolyl-arginine methyl chloride interacting genes (MeSH:C020924) in CTD
|
|
GS208908: GO:0071214 cellular response to abiotic stimulus
|
|
GS126117: zerumbone interacting genes (MeSH:C403304) in CTD
|
|
GS122457: WR 1065 interacting genes (MeSH:C020174) in CTD
|
|
GS182704: GO:0051172 negative regulation of nitrogen compound metabolic process
|
|
GS206380: GO:0001763 morphogenesis of a branching structure
|
|
GS184458: GO:0009892 negative regulation of metabolic process
|
|
GS122940: Dimethylnitrosamine interacting genes (MeSH:D004128) in CTD
|
|
GS198861: GO:0007167 enzyme linked receptor protein signaling pathway
|
|
GS121514: Paraquat interacting genes (MeSH:D010269) in CTD
|
|
GS164506: MP:0001698 decreased embryo size
|
|
GS186720: GO:0032844 regulation of homeostatic process
|
|
GS136932: vertebral trabecular bone trait 17 (Vtbt17, Published QTL Chr 15)
|
|
GS121888: methylselenic acid interacting genes (MeSH:C008493) in CTD
|
|
GS168559: MP:0002421 abnormal cell-mediated immunity
|
|
GS195608: GO:0070303 negative regulation of stress-activated protein kinase signaling cascade
|
|
GS178502: GO:0072186 metanephric cap morphogenesis
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS124313: bullatacin interacting genes (MeSH:C061022) in CTD
|
|
GS190247: GO:0032403 protein complex binding
|
|
GS198498: GO:0050801 ion homeostasis
|
|
GS165308: MP:0004848 abnormal liver size
|
|
GS123199: Tobacco Smoke Pollution interacting genes (MeSH:D014028) in CTD
|
|
GS123377: Glucose interacting genes (MeSH:D005947) in CTD
|
|
GS124417: Propylthiouracil interacting genes (MeSH:D011441) in CTD
|
|
GS182241: GO:0043068 positive regulation of programmed cell death
|
|
GS167437: MP:0000333 decreased bone marrow cell number
|
|
GS190477: GO:0090184 positive regulation of kidney development
|
|
GS165351: MP:0011705 absent fibroblast proliferation
|
|
GS125587: Reactive Oxygen Species interacting genes (MeSH:D017382) in CTD
|
|
GS201231: GO:0060548 negative regulation of cell death
|
|
GS166753: MP:0001935 decreased litter size
|
|
GS135724: dissociation of activity 2 (Disso2, Published QTL Chr 15)
|
|
GS168334: MP:0002619 abnormal lymphocyte morphology
|
|
GS186286: GO:0016485 protein processing
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS180913: GO:0071897 DNA biosynthetic process
|
|
GS165643: MP:0011088 partial neonatal lethality
|
|
GS121759: Vitamin K 3 interacting genes (MeSH:D024483) in CTD
|
|
GS196920: GO:0048878 chemical homeostasis
|
|
GS166858: MP:0000685 abnormal immune system morphology
|
|
GS179950: GO:0006259 DNA metabolic process
|
|
GS165850: MP:0000352 decreased cell proliferation
|
|
GS166749: MP:0002221 abnormal lymph organ size
|
|
GS163010: MP:0011181 increased hematopoietic cell number
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS206108: GO:2001141 regulation of RNA biosynthetic process
|
|
GS166085: MP:0011521 decreased placental labyrinth size
|
|
GS136865: T cell receptor induced activation 2 (Tria2, Published QTL Chr 15)
|
|
GS178588: GO:0045892 negative regulation of transcription, DNA-dependent
|
|
GS168624: MP:0008101 lymph node hypoplasia
|
|
GS177265: GO:0048731 system development
|
|
GS207925: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS167712: MP:0002416 abnormal proerythroblast morphology
|
|
GS124511: Shuangling Fuzheng anticancer preparation interacting genes (MeSH:C531092) in CTD
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS190872: GO:0060249 anatomical structure homeostasis
|
|
GS124954: styrene oxide interacting genes (MeSH:C013690) in CTD
|
|
GS121562: nickel subsulfide interacting genes (MeSH:C017557) in CTD
|
|
GS169763: MP:0008866 chromosomal instability
|
|
GS126466: Quercetin interacting genes (MeSH:D011794) in CTD
|
|
GS135453: bone length and organs 9 (Bod9, Published QTL Chr 15)
|
|
GS178357: GO:0071842 cellular component organization at cellular level
|
|
GS162953: MP:0002020 increased tumor incidence
|
|
GS166039: MP:0005352 small cranium
|
|
GS205367: GO:0010463 mesenchymal cell proliferation
|
|
GS201649: GO:0045638 negative regulation of myeloid cell differentiation
|
|
GS165023: MP:0011704 decreased fibroblast proliferation
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS123943: Curcumin interacting genes (MeSH:D003474) in CTD
|
|
GS193053: GO:0051604 protein maturation
|
|
GS162971: MP:0008011 intestine polyps
|
|
GS185145: GO:0043473 pigmentation
|
|
GS208675: GO:0022403 cell cycle phase
|
|
GS167325: MP:0002144 abnormal B cell differentiation
|
|
GS193888: GO:0051276 chromosome organization
|
|
GS179825: GO:0090095 regulation of metanephric cap mesenchymal cell proliferation
|
|
GS188743: GO:0002762 negative regulation of myeloid leukocyte differentiation
|
|
GS198505: GO:0006112 energy reserve metabolic process
|
|
GS167660: MP:0004200 decreased fetal size
|
|
GS201554: GO:0032200 telomere organization
|
|
GS188784: GO:0008134 transcription factor binding
|
|
GS205659: GO:0042493 response to drug
|
|
GS123208: Methimazole interacting genes (MeSH:D008713) in CTD
|
|
GS125965: acetylhydrazine interacting genes (MeSH:C014949) in CTD
|
|
GS122712: anthra(1,9-cd)pyrazol-6(2H)-one interacting genes (MeSH:C432165) in CTD
|
|
GS207285: GO:0032872 regulation of stress-activated MAPK cascade
|
|
GS168084: MP:0006410 abnormal common myeloid progenitor cell morphology
|
|
GS127931: Olfactory bulb - Allen Mouse Brain Atlas
|
|
GS188757: GO:0009887 organ morphogenesis
|
|
GS169995: MP:0004951 abnormal spleen weight
|
|
GS186483: GO:0006308 DNA catabolic process
|
|
GS193937: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS206237: GO:0042981 regulation of apoptotic process
|
|
GS179767: GO:0000976 transcription regulatory region sequence-specific DNA binding
|
|
GS204628: GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway
|
|
GS166409: MP:0002114 abnormal axial skeleton morphology
|
|
GS201696: GO:0010941 regulation of cell death
|
|
GS183696: GO:0003690 double-stranded DNA binding
|
|
GS169118: MP:0004198 abnormal fetal size
|
|
GS135383: bone density traits 6 (Bdt6, Published QTL Chr 15)
|
|
GS169641: MP:0008372 small malleus
|
|
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS186744: GO:0043226 organelle
|
|
GS136113: liver Gapd decay rate 2 (Lgdr2, Published QTL Chr 15)
|
|
GS182835: GO:0005622 intracellular
|
|
GS202468: GO:0070887 cellular response to chemical stimulus
|
|
GS180207: GO:0045596 negative regulation of cell differentiation
|
|
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS195541: GO:0000278 mitotic cell cycle
|
|
GS203482: GO:0044093 positive regulation of molecular function
|
|
GS192331: GO:0030262 apoptotic nuclear changes
|
|
GS170474: MP:0002938 white spotting
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS186634: GO:0044092 negative regulation of molecular function
|
|
GS208682: GO:0051302 regulation of cell division
|
|
GS127934: Retrohippocampal region - Allen Mouse Brain Atlas
|
|
GS136561: QTL for body weight independent of sex 4 (Qbis4, Published QTL Chr 15)
|
|
GS168683: MP:0000598 abnormal liver morphology
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS183471: GO:0048145 regulation of fibroblast proliferation
|
|
GS190830: GO:0052548 regulation of endopeptidase activity
|
|
GS164145: MP:0004247 small pancreas
|
|
GS185545: GO:0044212 transcription regulatory region DNA binding
|
|
GS168352: MP:0008758 abnormal T cell receptor beta chain V(D)J recombination
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS180190: GO:0051329 interphase of mitotic cell cycle
|
|
GS200341: GO:0051179 localization
|
|
GS164346: MP:0006335 abnormal hearing electrophysiology
|
|
GS205645: GO:0008134 transcription factor binding
|
|
GS207286: GO:0032873 negative regulation of stress-activated MAPK cascade
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS168336: MP:0000367 abnormal coat/ hair morphology
|
|
GS163052: MP:0000266 abnormal heart morphology
|
|
GS202371: GO:0044212 transcription regulatory region DNA binding
|
|
GS126479: bromochloroacetic acid interacting genes (MeSH:C099813) in CTD
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS127012: Raloxifene interacting genes (MeSH:D020849) in CTD
|
|
GS125913: Phenytoin interacting genes (MeSH:D010672) in CTD
|
|
GS189510: GO:0001763 morphogenesis of a branching structure
|
|
GS126316: Acetylcysteine interacting genes (MeSH:D000111) in CTD
|
|
GS125353: Oleanolic Acid interacting genes (MeSH:D009828) in CTD
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS124118: vinyl carbamate interacting genes (MeSH:C017963) in CTD
|
|
GS196930: GO:0065007 biological regulation
|
|
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS136225: mandible length 17 (Manln17, Published QTL Chr 15)
|
|
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS123951: Calcium Chloride interacting genes (MeSH:D002122) in CTD
|
|
GS192215: GO:2000278 regulation of DNA biosynthetic process
|
|
GS195660: GO:0061138 morphogenesis of a branching epithelium
|
|
GS122791: oxaliplatin interacting genes (MeSH:C030110) in CTD
|
|
GS125106: 1,4-phenylenebis(methylene)selenocyanate interacting genes (MeSH:C074153) in CTD
|
|
GS167542: MP:0001790 abnormal immune system physiology
|
|
GS207732: GO:0052547 regulation of peptidase activity
|
|
GS203058: GO:0048519 negative regulation of biological process
|
|
GS183900: GO:0009582 detection of abiotic stimulus
|
|
GS196968: GO:0051329 interphase of mitotic cell cycle
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS201264: GO:0009890 negative regulation of biosynthetic process
|
|
GS207853: GO:0010332 response to gamma radiation
|
|
GS164023: MP:0001961 abnormal reflex
|
|
GS209284: GO:0010627 regulation of intracellular protein kinase cascade
|
|
GS166272: MP:0000288 abnormal pericardium morphology
|
|
GS165489: MP:0001700 abnormal embryo turning
|
|
GS124506: bicyclol interacting genes (MeSH:C477843) in CTD
|
|
GS123759: Testosterone interacting genes (MeSH:D013739) in CTD
|
|
GS123468: Mestranol interacting genes (MeSH:D008656) in CTD
|
|
GS175529: HP:0000001 All
|
|
GS190174: GO:0051054 positive regulation of DNA metabolic process
|
|
GS201262: GO:0009892 negative regulation of metabolic process
|
|
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS178813: GO:0046983 protein dimerization activity
|
|
GS170360: MP:0001828 abnormal T cell activation
|
|
GS169777: MP:0002398 abnormal bone marrow cell morphology/development
|
|
GS177538: GO:0072074 kidney mesenchyme development
|
|
GS126754: dibromoacetic acid interacting genes (MeSH:C088674) in CTD
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS115115: QTL for VEC in the LS x SS RI Strains
|
|
GS169409: MP:0004939 abnormal B cell morphology
|
|
GS121385: epicatechin gallate interacting genes (MeSH:C062669) in CTD
|
|
GS166250: MP:0008247 abnormal mononuclear cell morphology
|
|
GS126454: 1-Methyl-4-phenylpyridinium interacting genes (MeSH:D015655) in CTD
|
|
GS188506: GO:0010467 gene expression
|
|
GS193343: GO:0071887 leukocyte apoptotic process
|
|
GS208012: GO:0044464 cell part
|
|
GS126941: beryllium sulfate interacting genes (MeSH:C020711) in CTD
|
|
GS184843: GO:0045637 regulation of myeloid cell differentiation
|
|
GS186430: GO:0007243 intracellular protein kinase cascade
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS200867: GO:0043085 positive regulation of catalytic activity
|
|
GS123848: CP 31398 interacting genes (MeSH:C402665) in CTD
|
|
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS865: Sey_Pax6_Age_Reduced_Linear_Incr
|
|
GS207067: GO:0051054 positive regulation of DNA metabolic process
|
|
GS168422: MP:0000716 abnormal immune system cell morphology
|
|
GS185475: GO:0051782 negative regulation of cell division
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS193043: GO:0050954 sensory perception of mechanical stimulus
|
|
GS169284: MP:0005093 decreased B cell proliferation
|
|
GS195607: GO:0070302 regulation of stress-activated protein kinase signaling cascade
|
|
GS203796: GO:0072215 regulation of metanephros development
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS124969: theaflavin interacting genes (MeSH:C056068) in CTD
|
|
GS125445: Phenobarbital interacting genes (MeSH:D010634) in CTD
|
|
GS185005: GO:0050974 detection of mechanical stimulus involved in sensory perception
|
|
GS205623: GO:0009888 tissue development
|
|
GS185016: GO:0097193 intrinsic apoptotic signaling pathway
|
|
GS188820: GO:0032091 negative regulation of protein binding
|
|
GS203755: GO:0016265 death
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS169535: MP:0005397 hematopoietic system phenotype
|
|
GS165789: MP:0005369 muscle phenotype
|
|
GS193661: GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS122184: gamma-Linolenic Acid interacting genes (MeSH:D017965) in CTD
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS209576: GO:0072132 mesenchyme morphogenesis
|
|
GS178448: GO:0005634 nucleus
|
|
GS123071: 1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate interacting genes (MeSH:C477941) in CTD
|
|
GS180876: GO:0051240 positive regulation of multicellular organismal process
|
|
GS199635: GO:0005622 intracellular
|
|
GS195206: GO:0002520 immune system development
|
|
GS191372: GO:0005819 spindle
|
|
GS188798: GO:0042493 response to drug
|
|
GS208795: GO:0015980 energy derivation by oxidation of organic compounds
|
|
GS124889: lingzhi interacting genes (MeSH:C027869) in CTD
|
|
GS125187: Sulindac interacting genes (MeSH:D013467) in CTD
|
|
GS178011: GO:2001220 negative regulation of G2 phase of mitotic cell cycle
|
|
GS121437: Fluorouracil interacting genes (MeSH:D005472) in CTD
|
|
GS165244: MP:0010771 integument phenotype
|
|
GS123751: Cadmium interacting genes (MeSH:D002104) in CTD
|
|
GS196941: GO:0008150 biological_process
|
|
GS195339: GO:0045892 negative regulation of transcription, DNA-dependent
|
|
GS124695: arsenic trioxide interacting genes (MeSH:C006632) in CTD
|
|
GS204029: GO:0010648 negative regulation of cell communication
|
|
GS190893: GO:0030154 cell differentiation
|
|
GS166564: MP:0000692 small spleen
|
|
GS201256: GO:0044422 organelle part
|
|
GS192344: GO:0010629 negative regulation of gene expression
|
|
GS170158: MP:0000074 abnormal neurocranium morphology
|
|
GS126146: 4-hydroxy-N-desmethyltamoxifen interacting genes (MeSH:C055492) in CTD
|
|
GS193537: GO:0007605 sensory perception of sound
|
|
GS196282: GO:0012501 programmed cell death
|
|
GS123995: methaneselenol interacting genes (MeSH:C019003) in CTD
|
|
GS183899: GO:0009581 detection of external stimulus
|
|
GS165615: MP:0002123 abnormal hematopoiesis
|
|
GS168634: MP:0000373 belly spot
|
|
GS121454: 3-xylene interacting genes (MeSH:C031285) in CTD
|
|
GS205472: GO:0009416 response to light stimulus
|
|
GS206192: GO:0048583 regulation of response to stimulus
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS195493: GO:0072203 cell proliferation involved in metanephros development
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS199267: GO:0043234 protein complex
|
|
GS170329: MP:0008754 abnormal T cell receptor V(D)J recombination
|
|
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS124515: 1,1-diethyl-2-hydroxy-2-nitrosohydrazine interacting genes (MeSH:C084012) in CTD
|
|
GS178470: GO:2001056 positive regulation of cysteine-type endopeptidase activity
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS126006: Piperonyl Butoxide interacting genes (MeSH:D010882) in CTD
|
|
GS207079: GO:2001020 regulation of response to DNA damage stimulus
|
|
GS202080: GO:0051252 regulation of RNA metabolic process
|
|
GS208051: GO:0002521 leukocyte differentiation
|
|
GS169827: MP:0005387 immune system phenotype
|
|
GS209577: GO:0072131 kidney mesenchyme morphogenesis
|
|
GS163620: MP:0002086 abnormal extraembryonic tissue morphology
|
|
GS125596: Teniposide interacting genes (MeSH:D013713) in CTD
|
|
GS189572: GO:0008633 activation of pro-apoptotic gene products
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS184629: GO:0005515 protein binding
|
|
GS169603: MP:0001672 abnormal embryogenesis/ development
|
|
GS169111: MP:0004197 abnormal fetal growth/weight/body size
|
|
GS177341: GO:0045655 regulation of monocyte differentiation
|
|
GS123568: 4-hydroxy-equilenin interacting genes (MeSH:C065250) in CTD
|
|
GS170236: MP:0005452 abnormal adipose tissue amount
|
|
GS167439: MP:0000443 abnormal snout morphology
|
|
GS210608: GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS196591: GO:0090096 positive regulation of metanephric cap mesenchymal cell proliferation
|
|
GS122904: Reserpine interacting genes (MeSH:D012110) in CTD
|
|
GS170601: MP:0005621 abnormal cell physiology
|
|
GS169095: MP:0004924 abnormal behavior
|
|
GS166718: MP:0002169 no abnormal phenotype detected
|
|
GS122736: Piroxicam interacting genes (MeSH:D010894) in CTD
|
|
GS205390: GO:0030224 monocyte differentiation
|
|
GS201160: GO:2000046 regulation of G2 phase of mitotic cell cycle
|
|
GS204438: GO:0051128 regulation of cellular component organization
|
|
GS194172: GO:0006915 apoptotic process
|
|
GS87011: Table S2: List of Cocaine-Treated HDAC5 KO vs. Cocaine-Treated WT Significantly Regulated Genes. [DRG]
provisional
|
|
GS135992: hepatic fibrogenesis 1 (Hfib1, Published QTL Chr 15)
|
|
GS164022: MP:0008246 abnormal leukocyte morphology
|
|
GS194586: GO:0002376 immune system process
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS123543: 3-adenin-9-yl-2-hydroxypropanoic acid isobutyl ester interacting genes (MeSH:C048336) in CTD
|
|
GS181872: GO:0051301 cell division
|
|
GS164742: MP:0001732 postnatal growth retardation
|
|
GS136012: heart rate quantitative locus 2 (Hrq2, Published QTL Chr 15)
|
|
GS166405: MP:0002111 abnormal tail morphology
|
|
GS183756: GO:0010605 negative regulation of macromolecule metabolic process
|
|
GS185008: GO:0097190 apoptotic signaling pathway
|
|
GS136478: periosteal circumference 3 (Pcir3, Published QTL Chr 15)
|
|
GS127924: Cerebral cortex - Allen Mouse Brain Atlas
|
|
GS170545: MP:0002022 increased lymphoma incidence
|
|
GS126832: N-caproylsphingosine interacting genes (MeSH:C101954) in CTD
|
|
GS135437: bone mineral density 37 (Bmd37, Published QTL Chr 15)
|
|
GS166311: MP:0009107 abnormal pancreas weight
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS124534: Norepinephrine interacting genes (MeSH:D009638) in CTD
|
|
GS210537: GO:2000602 regulation of interphase of mitotic cell cycle
|
|
GS192636: GO:0072132 mesenchyme morphogenesis
|
|
GS192471: GO:0048869 cellular developmental process
|
|
GS191727: GO:0008283 cell proliferation
|
|
GS190111: GO:0006338 chromatin remodeling
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS125686: 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol interacting genes (MeSH:C054649) in CTD
|
|
GS186482: GO:0006309 apoptotic DNA fragmentation
|
|
GS187347: GO:0006352 DNA-dependent transcription, initiation
|
|
GS127937: Striatum-like amygdalar nuclei - Allen Mouse Brain Atlas
|
|
GS189202: GO:0010952 positive regulation of peptidase activity
|
|
GS168848: MP:0002452 abnormal antigen presenting cell physiology
|
|
GS124275: 4-fluorobenzoyl-TN-14003 interacting genes (MeSH:C477728) in CTD
|
|
GS168366: MP:0000109 abnormal parietal bone morphology
|
|
GS126291: Dactinomycin interacting genes (MeSH:D003609) in CTD
|
|
GS126594: Nucleosides interacting genes (MeSH:D009705) in CTD
|
|
GS171916: HP:0002665 Lymphoma
|
|
GS182981: GO:0043067 regulation of programmed cell death
|
|
GS190148: GO:0060485 mesenchyme development
|
|
GS136551: proteinuria 4 (Ptnu4, Published QTL Chr 15)
|
|
GS193237: GO:0031325 positive regulation of cellular metabolic process
|
|
GS115121: Loss of righting induced by ethanol 5
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS184452: GO:0044422 organelle part
|
|
GS195596: GO:0010564 regulation of cell cycle process
|
|
GS125182: Vitamin A interacting genes (MeSH:D014801) in CTD
|
|
GS124759: Ammonium Chloride interacting genes (MeSH:D000643) in CTD
|
|
GS184551: GO:0007005 mitochondrion organization
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS170442: MP:0010866 abnormal prenatal body size
|
|
GS194602: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS124719: perchlorate interacting genes (MeSH:C494474) in CTD
|
|
GS125634: trichostatin A interacting genes (MeSH:C012589) in CTD
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS170151: MP:0001716 abnormal placenta labyrinth morphology
|
|
GS125409: Triiodothyronine interacting genes (MeSH:D014284) in CTD
|
|
GS207776: GO:0060249 anatomical structure homeostasis
|
|
GS168319: MP:0004470 small nasal bone
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS205935: GO:0043408 regulation of MAPK cascade
|
|
GS135836: fluctuating asymmetry QTL 9 (Faq9, Published QTL Chr 15)
|
|
GS190314: GO:0035295 tube development
|
|
GS165539: MP:0005375 adipose tissue phenotype
|
|
GS166611: MP:0002835 abnormal cranial suture morphology
|
|
GS167534: MP:0009145 abnormal pancreatic acinus morphology
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS207069: GO:0051052 regulation of DNA metabolic process
|
|
GS193009: GO:0042127 regulation of cell proliferation
|
|
GS201310: GO:0006873 cellular ion homeostasis
|
|
GS163637: MP:0004028 chromosome breakage
|
|
GS197275: GO:0033554 cellular response to stress
|
|
GS125402: Diethylnitrosamine interacting genes (MeSH:D004052) in CTD
|
|
GS190067: GO:0018130 heterocycle biosynthetic process
|
|
GS83983: cocaine related behavior 14 (Cocrb14, Published QTL, Chr 15)
|
|
GS163609: MP:0008781 abnormal B cell apoptosis
|
|
GS188308: GO:0010243 response to organic nitrogen
|
|
GS198394: GO:0050679 positive regulation of epithelial cell proliferation
|
|
GS163280: MP:0008043 abnormal NK cell number
|
|
GS178356: GO:0071845 cellular component disassembly at cellular level
|
|
GS180713: GO:0042471 ear morphogenesis
|
|
GS205266: GO:0032774 RNA biosynthetic process
|
|
GS124312: sodium arsenite interacting genes (MeSH:C017947) in CTD
|
|
GS195977: GO:0007154 cell communication
|
|
GS202079: GO:0051253 negative regulation of RNA metabolic process
|
|
GS136488: predicted fat percentage 4 (Pfat4, Published QTL Chr 15)
|
|
GS192171: GO:0000165 MAPK cascade
|
|
GS166535: MP:0010865 prenatal growth retardation
|
|
GS177959: GO:0051726 regulation of cell cycle
|
|
GS204627: GO:0007179 transforming growth factor beta receptor signaling pathway
|
|
GS209575: GO:0072133 metanephric mesenchyme morphogenesis
|
|
GS185637: GO:0070887 cellular response to chemical stimulus
|
|
GS177784: GO:0006325 chromatin organization
|
|
GS194905: GO:0008219 cell death
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS198274: GO:0035556 intracellular signal transduction
|
|
GS124531: limonene interacting genes (MeSH:C008281) in CTD
|
|
GS124674: Glutethimide interacting genes (MeSH:D005984) in CTD
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS183630: GO:0002682 regulation of immune system process
|
|
GS127939: Thalamus - Allen Mouse Brain Atlas
|
|
GS178453: GO:0002520 immune system development
|
|
GS182469: GO:0043234 protein complex
|
|
GS168090: MP:0000175 absent bone marrow cell
|
|
GS195570: GO:0046983 protein dimerization activity
|
|
GS206953: GO:0018130 heterocycle biosynthetic process
|
|
GS125069: Sodium Selenite interacting genes (MeSH:D018038) in CTD
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS124457: Mustard Gas interacting genes (MeSH:D009151) in CTD
|
|
GS192360: GO:0090305 nucleic acid phosphodiester bond hydrolysis
|
|
GS188751: GO:0044430 cytoskeletal part
|
|
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS180164: GO:0008150 biological_process
|
|
GS177357: GO:0003676 nucleic acid binding
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS165437: MP:0000438 abnormal cranium morphology
|
|
GS186317: GO:0002573 myeloid leukocyte differentiation
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS127310: 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone interacting genes (MeSH:C016583) in CTD
|
|
GS124286: Benzene interacting genes (MeSH:D001554) in CTD
|
|
GS177214: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS182956: GO:0035239 tube morphogenesis
|
|
GS165205: MP:0001718 abnormal visceral yolk sac morphology
|
|
GS195254: GO:0072186 metanephric cap morphogenesis
|
|
GS180482: GO:0033554 cellular response to stress
|
|
GS186562: GO:0009653 anatomical structure morphogenesis
|
|
GS188107: GO:0050906 detection of stimulus involved in sensory perception
|
|
GS123048: Tretinoin interacting genes (MeSH:D014212) in CTD
|
|
GS124490: Fructose interacting genes (MeSH:D005632) in CTD
|
|
GS189666: GO:2000116 regulation of cysteine-type endopeptidase activity
|
|
GS207858: GO:0009059 macromolecule biosynthetic process
|
|
GS191745: GO:0051302 regulation of cell division
|
|
GS209611: GO:0055082 cellular chemical homeostasis
|
|
GS127930: Midbrain - Allen Mouse Brain Atlas
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS163761: MP:0003840 abnormal coronal suture morphology
|
|
GS188707: GO:0045786 negative regulation of cell cycle
|
|
GS190954: GO:0009056 catabolic process
|
|
GS126142: Staurosporine interacting genes (MeSH:D019311) in CTD
|
|
GS122305: resveratrol interacting genes (MeSH:C059514) in CTD
|
|
GS135706: diabetes susceptibility QTL 2 (Dbsq2, Published QTL Chr 15)
|
|
GS163635: MP:0001933 abnormal litter size
|
|
GS177813: GO:0031974 membrane-enclosed lumen
|
|
GS124594: 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid interacting genes (MeSH:C472791) in CTD
|
|
GS166969: MP:0011519 abnormal placenta labyrinth size
|
|
GS183097: GO:0043279 response to alkaloid
|
|
GS178782: GO:0045656 negative regulation of monocyte differentiation
|
|
GS122408: vorinostat interacting genes (MeSH:C111237) in CTD
|
|
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS164257: MP:0002085 abnormal embryonic tissue morphology
|
|
GS166825: MP:0000462 abnormal digestive system morphology
|
|
GS178904: GO:0061138 morphogenesis of a branching epithelium
|
|
GS169371: MP:0000929 open neural tube
|
|
GS186179: GO:0045934 negative regulation of nucleobase-containing compound metabolic process
|
|
GS122308: Nitrofurazone interacting genes (MeSH:D009583) in CTD
|
|
GS167566: MP:0005018 decreased T cell number
|
|
GS181604: GO:0050679 positive regulation of epithelial cell proliferation
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS202362: GO:0006974 response to DNA damage stimulus
|
|
GS206757: GO:0072001 renal system development
|
|
GS201949: GO:0044699 single-organism process
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS184044: GO:0072111 cell proliferation involved in kidney development
|
|
GS124975: Lithium Chloride interacting genes (MeSH:D018021) in CTD
|
|
GS189244: GO:0097285 cell-type specific apoptotic process
|
|
GS168086: MP:0000172 abnormal bone marrow cell number
|
|
GS186526: GO:0005654 nucleoplasm
|
|
GS168549: MP:0000477 abnormal intestine morphology
|
|
GS178242: GO:0001159 core promoter proximal region DNA binding
|
|
GS190176: GO:0051052 regulation of DNA metabolic process
|
|
GS190950: GO:0009059 macromolecule biosynthetic process
|
|
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS123883: Methylnitrosourea interacting genes (MeSH:D008770) in CTD
|
|
GS164320: MP:0003861 abnormal nervous system development
|
|
GS166154: MP:0011098 complete embryonic lethality during organogenesis
|
|
GS178461: GO:0009987 cellular process
|
|
GS122110: Cyproterone Acetate interacting genes (MeSH:D017373) in CTD
|
|
GS123271: DDT interacting genes (MeSH:D003634) in CTD
|
|
GS201305: GO:0006879 cellular iron ion homeostasis
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS164838: MP:0006358 absent pinna reflex
|
|
GS188230: GO:0033044 regulation of chromosome organization
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS177856: GO:0002902 regulation of B cell apoptotic process
|
|
GS195776: GO:0015671 oxygen transport
|
|
GS210507: GO:0006950 response to stress
|
|
GS126254: rebamipide interacting genes (MeSH:C052785) in CTD
|
|
GS169973: MP:0002006 tumorigenesis
|
|
GS191043: GO:0005996 monosaccharide metabolic process
|
|
GS203276: GO:0007243 intracellular protein kinase cascade
|
|
GS192667: GO:0055080 cation homeostasis
|
|
GS181892: GO:0048523 negative regulation of cellular process
|
|
GS205471: GO:0009411 response to UV
|
|
GS193268: GO:0005575 cellular_component
|
|
GS123865: catechol interacting genes (MeSH:C034221) in CTD
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS169087: MP:0011702 abnormal fibroblast proliferation
|
|
GS127923: Cerebellum - Allen Mouse Brain Atlas
|
|
GS209215: GO:0007166 cell surface receptor signaling pathway
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS190829: GO:0052547 regulation of peptidase activity
|
|
GS207081: GO:2001022 positive regulation of response to DNA damage stimulus
|
|
GS121651: Sodium Dodecyl Sulfate interacting genes (MeSH:D012967) in CTD
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS199873: GO:0010950 positive regulation of endopeptidase activity
|
|
GS163271: MP:0006042 increased apoptosis
|
|
GS125159: Rotenone interacting genes (MeSH:D012402) in CTD
|
|
GS191721: GO:0008284 positive regulation of cell proliferation
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS126040: Tetracycline interacting genes (MeSH:D013752) in CTD
|
|
GS125125: 2-Acetylaminofluorene interacting genes (MeSH:D015073) in CTD
|
|
GS164881: MP:0005068 abnormal NK cell morphology
|
|
GS166746: MP:0002224 abnormal spleen size
|
|
GS205610: GO:0044430 cytoskeletal part
|
|
GS208526: GO:0055065 metal ion homeostasis
|
|
GS124778: beta Carotene interacting genes (MeSH:D019207) in CTD
|
|
GS165522: MP:0009674 decreased birth weight
|
|
GS123595: Progesterone interacting genes (MeSH:D011374) in CTD
|
|
GS125959: Cisplatin interacting genes (MeSH:D002945) in CTD
|
|
GS207123: GO:0071482 cellular response to light stimulus
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS168011: MP:0010833 abnormal memory T cell morphology
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS192986: GO:0006996 organelle organization
|
|
GS192279: GO:0007166 cell surface receptor signaling pathway
|
|
GS163072: MP:0000049 abnormal middle ear morphology
|
|
GS187229: GO:0043583 ear development
|
|
GS165466: MP:0003632 abnormal nervous system morphology
|
|
GS165528: MP:0005379 endocrine/exocrine gland phenotype
|
|
GS163956: MP:0011180 abnormal hematopoietic cell number
|
|
GS169835: MP:0005389 reproductive system phenotype
|
|
GS206191: GO:0048584 positive regulation of response to stimulus
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS166706: MP:0002166 altered tumor susceptibility
|
|
GS124165: Hydrogen Peroxide interacting genes (MeSH:D006861) in CTD
|
|
GS167537: MP:0009146 abnormal pancreatic acinar cell morphology
|
|
GS170539: MP:0004030 induced chromosome breakage
|
|
GS135560: CD8 T cell subset 3 (Cd8ts3, Published QTL Chr 15)
|
|
GS201132: GO:0010646 regulation of cell communication
|
|
GS123707: Oxidopamine interacting genes (MeSH:D016627) in CTD
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS183472: GO:0048144 fibroblast proliferation
|
|
GS191106: GO:0044464 cell part
|
|
GS182095: GO:0080135 regulation of cellular response to stress
|
|
GS205363: GO:0010464 regulation of mesenchymal cell proliferation
|
|
GS179517: GO:0012501 programmed cell death
|
|
GS177570: GO:0016043 cellular component organization
|
|
GS169291: MP:0005094 abnormal T cell proliferation
|
|
GS208893: GO:0005856 cytoskeleton
|
|
GS186227: GO:0090304 nucleic acid metabolic process
|
|
GS203569: GO:0032844 regulation of homeostatic process
|
|
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
|
|
GS168593: MP:0002088 abnormal embryonic growth/weight/body size
|
|
GS192669: GO:0055082 cellular chemical homeostasis
|
|
GS209419: GO:0002053 positive regulation of mesenchymal cell proliferation
|
|
GS164754: MP:0004029 spontaneous chromosome breakage
|
|
GS167991: MP:0002401 abnormal lymphopoiesis
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS206066: GO:0010952 positive regulation of peptidase activity
|
|
GS191170: GO:2000573 positive regulation of DNA biosynthetic process
|
|
GS125390: Aspirin interacting genes (MeSH:D001241) in CTD
|
|
GS127139: Indomethacin interacting genes (MeSH:D007213) in CTD
|
|
GS182924: GO:0000987 core promoter proximal region sequence-specific DNA binding
|
|
GS193662: GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS181267: GO:0048568 embryonic organ development
|
|
GS190023: GO:0001657 ureteric bud development
|
|
GS123990: perfluorooctanoic acid interacting genes (MeSH:C023036) in CTD
|
|
GS121147: Azacitidine interacting genes (MeSH:D001374) in CTD
|
|
GS178247: GO:0070888 E-box binding
|
|
GS198887: GO:0080135 regulation of cellular response to stress
|
|
GS170460: MP:0008217 abnormal B cell activation
|
|
GS177311: GO:1901361 organic cyclic compound catabolic process
|
|
GS135731: dietary obesity 3 (Dob3, Published QTL Chr 15)
|
|
GS184353: GO:2000046 regulation of G2 phase of mitotic cell cycle
|
|
GS180821: GO:0048147 negative regulation of fibroblast proliferation
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS191738: GO:0022403 cell cycle phase
|
|
GS178803: GO:0051336 regulation of hydrolase activity
|
|
GS164133: MP:0005076 abnormal cell differentiation
|
|
GS169176: MP:0000759 abnormal skeletal muscle morphology
|
|
GS124479: matrine interacting genes (MeSH:C034244) in CTD
|
|
GS209247: GO:0000085 G2 phase of mitotic cell cycle
|
|
GS178840: GO:0010564 regulation of cell cycle process
|
|
GS187439: GO:0051319 G2 phase
|
|
GS169133: MP:0002442 abnormal leukocyte physiology
|
|
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS125578: 3-deazaneplanocin interacting genes (MeSH:C048460) in CTD
|
|
GS185033: GO:0048598 embryonic morphogenesis
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS178155: GO:0008219 cell death
|
|
GS122187: Prostaglandin D2 interacting genes (MeSH:D015230) in CTD
|
|
GS169114: MP:0004196 abnormal prenatal growth/weight/body size
|
|
GS189374: GO:0042981 regulation of apoptotic process
|
|
GS191640: GO:0044265 cellular macromolecule catabolic process
|
|
GS168710: MP:0001648 abnormal apoptosis
|
|
GS127184: fucoidan interacting genes (MeSH:C007789) in CTD
|
|
GS121718: Naloxone interacting genes (MeSH:D009270) in CTD
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS187708: GO:0009893 positive regulation of metabolic process
|
|
GS209762: GO:0070491 repressing transcription factor binding
|
|
GS123653: Diosgenin interacting genes (MeSH:D004144) in CTD
|
|
GS122740: hydroxytamoxifen interacting genes (MeSH:C475919) in CTD
|
|
GS204232: GO:0001071 nucleic acid binding transcription factor activity
|
|
GS206898: GO:0001655 urogenital system development
|
|
GS121627: Glycerol interacting genes (MeSH:D005990) in CTD
|
|
GS192479: GO:0002053 positive regulation of mesenchymal cell proliferation
|
|
GS168502: MP:0002058 neonatal lethality
|
|
GS181611: GO:0050673 epithelial cell proliferation
|
|
GS203019: GO:0045934 negative regulation of nucleobase-containing compound metabolic process
|
|
GS189748: GO:0050790 regulation of catalytic activity
|
|
GS124553: tetra(4-N-methylpyridyl)porphine interacting genes (MeSH:C021096) in CTD
|
|
GS197478: GO:0009628 response to abiotic stimulus
|
|
GS206354: GO:0023057 negative regulation of signaling
|
|
GS122027: hydroquinone interacting genes (MeSH:C031927) in CTD
|
|
GS164836: MP:0008374 abnormal malleus manubrium morphology
|
|
GS205338: GO:0051094 positive regulation of developmental process
|
|
GS167633: MP:0000029 abnormal malleus morphology
|
|
GS163610: MP:0008782 increased B cell apoptosis
|
|
GS135406: body growth late QTL 16 (Bglq16, Published QTL Chr 15)
|
|
GS200373: GO:0060070 canonical Wnt receptor signaling pathway
|
|
GS170084: MP:0000701 abnormal lymph node size
|
|
GS191593: GO:0055065 metal ion homeostasis
|
|
GS121601: 1-Naphthylisothiocyanate interacting genes (MeSH:D015058) in CTD
|
|
GS164059: MP:0006325 impaired hearing
|
|
GS183575: GO:0060070 canonical Wnt receptor signaling pathway
|
|
GS188482: GO:0051094 positive regulation of developmental process
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS177470: GO:0007346 regulation of mitotic cell cycle
|
|
GS184883: GO:0010942 positive regulation of cell death
|
|
GS197892: GO:0043228 non-membrane-bounded organelle
|
|
GS192256: GO:0007049 cell cycle
|
|
GS189484: GO:0023052 signaling
|
|
GS195143: GO:0016055 Wnt receptor signaling pathway
|
|
GS195643: GO:0003677 DNA binding
|
|
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS125333: oligofectamine interacting genes (MeSH:C484027) in CTD
|
|
GS209928: GO:0006996 organelle organization
|
|
GS184317: GO:0009790 embryo development
|
|
GS196532: GO:0000975 regulatory region DNA binding
|
|
GS127926: Hippocampal region - Allen Mouse Brain Atlas
|
|
GS169828: MP:0005386 behavior/neurological phenotype
|
|
GS123287: Trichloroacetic Acid interacting genes (MeSH:D014238) in CTD
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS125893: Tetradecanoylphorbol Acetate interacting genes (MeSH:D013755) in CTD
|
|
GS121847: Theophylline interacting genes (MeSH:D013806) in CTD
|
|
GS206544: GO:2000112 regulation of cellular macromolecule biosynthetic process
|
|
GS169832: MP:0005381 digestive/alimentary phenotype
|
|
GS197593: GO:0006091 generation of precursor metabolites and energy
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS208021: GO:0051345 positive regulation of hydrolase activity
|
|
GS198684: GO:0048523 negative regulation of cellular process
|
|
GS121697: pivalyloxymethyl butyrate interacting genes (MeSH:C070441) in CTD
|
|
GS205331: GO:0051093 negative regulation of developmental process
|
|
GS167627: MP:0005460 abnormal leukopoiesis
|
|
GS208717: GO:2000027 regulation of organ morphogenesis
|
|
GS122626: pregna-4,17-diene-3,16-dione interacting genes (MeSH:C023617) in CTD
|
|
GS167651: MP:0001944 abnormal pancreas morphology
|
|
GS199501: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS135269: alopecia areata 4 (Alaa4, Published QTL Chr 15)
|
|
GS178504: GO:0072185 metanephric cap development
|
|
GS180142: GO:0048878 chemical homeostasis
|
|
GS126446: Methapyrilene interacting genes (MeSH:D008701) in CTD
|
|
GS179789: GO:0005730 nucleolus
|
|
GS190955: GO:0009057 macromolecule catabolic process
|
|
GS206329: GO:0060255 regulation of macromolecule metabolic process
|
|
GS126486: 2,4,5,2',4',5'-hexachlorobiphenyl interacting genes (MeSH:C014024) in CTD
|
|
GS205084: GO:0033044 regulation of chromosome organization
|
|
GS115114: 10% Ethanol Preference
|
|
GS195199: GO:0005634 nucleus
|
|
GS193234: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS163728: MP:0005154 increased B cell proliferation
|
|
GS195538: GO:0045656 negative regulation of monocyte differentiation
|
|
GS163803: MP:0003631 nervous system phenotype
|
|
GS36576: Neocortex Gene expression correlates of Novel Open Field Number of urinations in Females BXD
|
|
GS125040: Thioacetamide interacting genes (MeSH:D013853) in CTD
|
|
GS194757: GO:2001220 negative regulation of G2 phase of mitotic cell cycle
|
|
GS125371: Cadmium Chloride interacting genes (MeSH:D019256) in CTD
|
|
GS205930: GO:0043409 negative regulation of MAPK cascade
|
|
GS189240: GO:2001141 regulation of RNA biosynthetic process
|
|
GS192427: GO:0050910 detection of mechanical stimulus involved in sensory perception of sound
|
|
GS121800: aluminum citrate interacting genes (MeSH:C455846) in CTD
|
|
GS165386: MP:0001262 decreased body weight
|
|
GS190480: GO:0090183 regulation of kidney development
|
|
GS166615: MP:0003410 abnormal artery development
|
|
GS190386: GO:0031324 negative regulation of cellular metabolic process
|
|
GS182820: GO:0060429 epithelium development
|
|
GS186178: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
|
|
GS165535: MP:0005370 liver/biliary system phenotype
|
|
GS135320: accelerator of polyoma-induced mammary tumors 1 (Apmt1, Published QTL Chr 15)
|
|
GS182325: GO:0051716 cellular response to stimulus
|
|
GS121921: Sulfur Dioxide interacting genes (MeSH:D013458) in CTD
|
|
GS124561: Gemfibrozil interacting genes (MeSH:D015248) in CTD
|
|
GS209951: GO:0042127 regulation of cell proliferation
|
|
GS167614: MP:0003934 abnormal pancreas development
|
|
GS169391: MP:0002066 abnormal motor capabilities/coordination/movement
|
|
GS169390: MP:0002067 abnormal sensory capabilities/reflexes/nociception
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS167714: MP:0002414 abnormal myeloblast morphology/development
|
|
GS168361: MP:0000102 abnormal nasal bone morphology
|
|
GS124920: Butyrates interacting genes (MeSH:D002087) in CTD
|
|
GS167067: MP:0002217 small lymph nodes
|
|
GS125090: monomethylarsonous acid interacting genes (MeSH:C406082) in CTD
|
|
GS207370: GO:0090184 positive regulation of kidney development
|
|
GS189953: GO:0043393 regulation of protein binding
|
|
GS127028: Mifepristone interacting genes (MeSH:D015735) in CTD
|
|
GS210170: GO:0030097 hemopoiesis
|
|
GS183308: GO:0060675 ureteric bud morphogenesis
|
|
GS168687: MP:0000592 short tail
|
|
GS200266: GO:0048146 positive regulation of fibroblast proliferation
|
|
GS135392: body growth early QTL 14 (Bgeq14, Published QTL Chr 15)
|
|
GS181666: GO:0019439 aromatic compound catabolic process
|
|
GS165518: MP:0010766 abnormal NK cell physiology
|
|
GS165869: MP:0002138 abnormal hepatobiliary system morphology
|
|
GS193991: GO:0048731 system development
|
|
GS178593: GO:2000108 positive regulation of leukocyte apoptotic process
|
|
GS163294: MP:0000218 increased leukocyte cell number
|
|
GS183891: GO:0002009 morphogenesis of an epithelium
|
|
GS127929: Medulla - Allen Mouse Brain Atlas
|
|
GS181667: GO:0019438 aromatic compound biosynthetic process
|
|
GS166123: MP:0002102 abnormal ear morphology
|
|
GS179884: GO:0001783 B cell apoptotic process
|
|
GS188511: GO:0010468 regulation of gene expression
|
|
GS186067: GO:0050877 neurological system process
|
|
GS122944: Dimethyl Sulfoxide interacting genes (MeSH:D004121) in CTD
|
|
GS124711: Genistein interacting genes (MeSH:D019833) in CTD
|
|
GS126395: Chloroform interacting genes (MeSH:D002725) in CTD
|
|
GS193018: GO:0003008 system process
|
|
GS199781: GO:0043067 regulation of programmed cell death
|
|
GS125548: Doxorubicin interacting genes (MeSH:D004317) in CTD
|
|
GS186956: GO:0050982 detection of mechanical stimulus
|
|
GS122326: Tocopherols interacting genes (MeSH:D024505) in CTD
|
|
GS169767: MP:0002396 abnormal hematopoietic system morphology/development
|
|
GS184447: GO:0044424 intracellular part
|
|
GS193236: GO:0031326 regulation of cellular biosynthetic process
|
|
GS209725: GO:0000122 negative regulation of transcription from RNA polymerase II promoter
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS206359: GO:0000723 telomere maintenance
|
|
GS170085: MP:0000702 enlarged lymph nodes
|
|
GS196433: GO:0030003 cellular cation homeostasis
|
|
GS169290: MP:0005095 decreased T cell proliferation
|
|
GS206356: GO:0023051 regulation of signaling
|
|
GS122124: ferric nitrilotriacetate interacting genes (MeSH:C020326) in CTD
|
|
GS193072: GO:0060562 epithelial tube morphogenesis
|
|
GS163080: MP:0010273 increased classified tumor incidence
|
|
GS178360: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS191021: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS197555: GO:0007050 cell cycle arrest
|
|
GS199499: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS179824: GO:0090094 metanephric cap mesenchymal cell proliferation involved in metanephros development
|
|
GS203335: GO:0048513 organ development
|
|
GS170475: MP:0001622 abnormal vasculogenesis
|
|
GS188684: GO:0070013 intracellular organelle lumen
|
|
GS127138: gemcitabine interacting genes (MeSH:C056507) in CTD
|
|
GS166712: MP:0002161 abnormal fertility/fecundity
|
|
GS200690: GO:0002009 morphogenesis of an epithelium
|
|
GS208067: GO:0010558 negative regulation of macromolecule biosynthetic process
|
|
GS166860: MP:0000687 small lymphoid organs
|
|
GS190410: GO:0080134 regulation of response to stress
|
|
GS183188: GO:0009719 response to endogenous stimulus
|
|
GS179672: GO:0030003 cellular cation homeostasis
|
|
GS206901: GO:0001656 metanephros development
|
|
GS124810: Urethane interacting genes (MeSH:D014520) in CTD
|
|
GS123911: Ozone interacting genes (MeSH:D010126) in CTD
|
|
GS136053: IGF-1 serum levels 3 (Igf1sl3, Published QTL Chr 15)
|
|
GS182475: GO:0043233 organelle lumen
|
|
GS135690: directional asymmetry QTL 12 (Daq12, Published QTL Chr 15)
|
|
GS164534: MP:0002019 abnormal tumor incidence
|
|
GS210212: GO:0005575 cellular_component
|
|
GS195291: GO:0006355 regulation of transcription, DNA-dependent
|
|
GS164123: MP:0001574 abnormal oxygen level
|
|
GS205369: GO:0010468 regulation of gene expression
|
|
GS125601: Bucladesine interacting genes (MeSH:D003994) in CTD
|
|
GS181262: GO:0048562 embryonic organ morphogenesis
|
|
GS188762: GO:0009889 regulation of biosynthetic process
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS124805: decitabine interacting genes (MeSH:C014347) in CTD
|
|
GS194995: GO:0070888 E-box binding
|
|
GS207000: GO:0006338 chromatin remodeling
|
|
GS121219: beryllium fluoride interacting genes (MeSH:C035982) in CTD
|
|
GS136521: phospholipid transfer protein activity QTL 4 (Pltpq4, Published QTL Chr 15)
|
|
GS177447: GO:0006921 cellular component disassembly involved in execution phase of apoptosis
|
|
GS182979: GO:0043065 positive regulation of apoptotic process
|
|
GS125820: 4-hydroxy-2-nonenal interacting genes (MeSH:C027576) in CTD
|
|
GS164853: MP:0008376 small malleus manubrium
|
|
GS187370: GO:0001071 nucleic acid binding transcription factor activity
|
|
GS163818: MP:0002722 abnormal immune system organ morphology
|
|
GS207015: GO:0042592 homeostatic process
|
|
GS163044: MP:0008050 decreased memory T cell number
|
|
GS166570: MP:0000694 spleen hypoplasia
|
|
GS164261: MP:0002081 perinatal lethality
|
|
GS195139: GO:0055114 oxidation-reduction process
|
|
GS194038: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS122565: tetraarsenic tetrasulfide interacting genes (MeSH:C534735) in CTD
|
|
GS194703: GO:0051726 regulation of cell cycle
|
|
GS168396: MP:0010031 abnormal cranium size
|
|
GS190899: GO:0043005 neuron projection
|
|
GS164824: MP:0008375 short malleus manubrium
|
|
GS125600: Dibutyl Phthalate interacting genes (MeSH:D003993) in CTD
|
|
GS164747: MP:0000600 liver hypoplasia
|
|
GS163050: MP:0000260 abnormal angiogenesis
|
|
GS168282: MP:0004471 short nasal bone
|
|
GS168505: MP:0002052 decreased tumor incidence
|
|
GS170366: MP:0000245 abnormal erythropoiesis
|
|
GS193235: GO:0031327 negative regulation of cellular biosynthetic process
|
|
GS200268: GO:0048144 fibroblast proliferation
|
|
GS123916: Aflatoxin B1 interacting genes (MeSH:D016604) in CTD
|
|
GS210609: GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS168149: MP:0005508 abnormal skeleton morphology
|
|
GS187289: GO:0070230 positive regulation of lymphocyte apoptotic process
|
|
GS168294: MP:0003699 abnormal female reproductive system physiology
|
|
GS164263: MP:0002083 premature death
|
|
GS165616: MP:0002127 abnormal cardiovascular system morphology
|
|
GS169331: MP:0001663 abnormal digestive system physiology
|
|
GS210180: GO:0031326 regulation of cellular biosynthetic process
|
|
GS188244: GO:0051100 negative regulation of binding
|
|
GS123598: Paclitaxel interacting genes (MeSH:D017239) in CTD
|
|
GS121146: ochratoxin A interacting genes (MeSH:C025589) in CTD
|
|
GS208658: GO:0008285 negative regulation of cell proliferation
|
|
GS182834: GO:0005623 cell
|
|
GS188475: GO:0051093 negative regulation of developmental process
|
|
GS205622: GO:0009889 regulation of biosynthetic process
|
|
GS123827: alpha-hexachlorocyclohexane interacting genes (MeSH:C040534) in CTD
|
|
GS163680: MP:0002970 abnormal white adipose tissue morphology
|
|
GS197241: GO:0032204 regulation of telomere maintenance
|
|
GS115116: alcohol acceptance QTL 1 (Aaq1 , Published QTL, Chr 15)
|
|
GS124295: Polychlorinated Biphenyls interacting genes (MeSH:D011078) in CTD
|
|
GS189460: GO:0060255 regulation of macromolecule metabolic process
|
|
GS115112: Mean ethanol consumption 6 (Mec6, Published QTL, Chr 15)
|
|
GS201656: GO:0045637 regulation of myeloid cell differentiation
|
|
GS125268: Thiophenes interacting genes (MeSH:D013876) in CTD
|
|
GS168845: MP:0002459 abnormal B cell physiology
|
|
GS182474: GO:0043232 intracellular non-membrane-bounded organelle
|
|
GS164124: MP:0001575 cyanosis
|
|
GS123838: cyanoginosin LR interacting genes (MeSH:C057862) in CTD
|
|
GS14885: Co-expression cluster of Nicotine Dependence genes significantly expressed in the adolescent PFC, VS and Hippocampus.
|
|
GS168012: MP:0010832 lethality during fetal growth through weaning
|
|
GS166710: MP:0002163 abnormal gland morphology
|
|
GS178537: GO:0006355 regulation of transcription, DNA-dependent
|
|
GS185304: GO:0030424 axon
|
|
GS123975: 5,10,15,20-(etra(N-methyl-3-pyridyl))-26,28-diselenasapphyrin chloride interacting genes (MeSH:C499730) in CTD
|
|
GS196943: GO:0008152 metabolic process
|
|
GS199789: GO:0043069 negative regulation of programmed cell death
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS184743: GO:0048754 branching morphogenesis of a tube
|